The formation of 3-hydroxy-4-methoxyphenylalanine and 3-hydroxy-4-methoxyphenethylamine in plasma during L-DOPA therapy in patients with parkinson's disease.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.